The global heparin market was valued at approximately US$ 7.34 billion in 2024, and is projected to reach around US$ 8.20 billion by 2032, growing at a modest compound annual growth rate (CAGR) of about 1.6 % during the 2025-2032 period. This growth is being primarily driven by a rising incidence of cardiovascular disorders, deep-vein thrombosis, pulmonary...